- Home
- GEG vs CCEL Comparison
GEG vs CCEL Comparison
Compare GEG & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEG
- CCEL
- Stock Information
- Founded
- GEG 1994
- CCEL 1989
- Country
- GEG United States
- CCEL United States
- Employees
- GEG N/A
- CCEL N/A
- Industry
- GEG Computer Software: Prepackaged Software
- CCEL Managed Health Care
- Sector
- GEG Technology
- CCEL Health Care
- Exchange
- GEG Nasdaq
- CCEL Nasdaq
- Market Cap
- GEG 53.0M
- CCEL 56.8M
- IPO Year
- GEG N/A
- CCEL 1997
- Fundamental
- Price
- GEG $1.86
- CCEL $6.49
- Analyst Decision
- GEG
- CCEL Strong Buy
- Analyst Count
- GEG 0
- CCEL 1
- Target Price
- GEG N/A
- CCEL $8.50
- AVG Volume (30 Days)
- GEG 27.6K
- CCEL 16.0K
- Earning Date
- GEG 05-07-2025
- CCEL 04-14-2025
- Dividend Yield
- GEG N/A
- CCEL 3.92%
- EPS Growth
- GEG N/A
- CCEL N/A
- EPS
- GEG 0.00
- CCEL 0.05
- Revenue
- GEG $19,204,000.00
- CCEL $31,986,106.00
- Revenue This Year
- GEG N/A
- CCEL $2.21
- Revenue Next Year
- GEG N/A
- CCEL $0.98
- P/E Ratio
- GEG $17,382.82
- CCEL $129.11
- Revenue Growth
- GEG 73.74
- CCEL 2.05
- 52 Week Low
- GEG $1.70
- CCEL $5.35
- 52 Week High
- GEG $2.12
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- GEG 51.20
- CCEL 38.48
- Support Level
- GEG $1.79
- CCEL $6.27
- Resistance Level
- GEG $1.87
- CCEL $6.97
- Average True Range (ATR)
- GEG 0.05
- CCEL 0.62
- MACD
- GEG -0.00
- CCEL -0.11
- Stochastic Oscillator
- GEG 70.00
- CCEL 12.61
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.